Kenichi Matsuo

4.7k total citations
150 papers, 3.6k citations indexed

About

Kenichi Matsuo is a scholar working on Surgery, Oncology and Hepatology. According to data from OpenAlex, Kenichi Matsuo has authored 150 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Surgery, 68 papers in Oncology and 65 papers in Hepatology. Recurrent topics in Kenichi Matsuo's work include Hepatocellular Carcinoma Treatment and Prognosis (48 papers), Pancreatic and Hepatic Oncology Research (27 papers) and Colorectal Cancer Treatments and Studies (23 papers). Kenichi Matsuo is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (48 papers), Pancreatic and Hepatic Oncology Research (27 papers) and Colorectal Cancer Treatments and Studies (23 papers). Kenichi Matsuo collaborates with scholars based in Japan, United States and Chile. Kenichi Matsuo's co-authors include Kuniya Tanaka, Hiroshi Shimada, Itaru Endo, Shinji Togo, Yasuhiko Nagano, Michihiko Kuwano, Kimitoshi Kohno, William R. Jarnagin, Kazuhisa Takeda and Michio Ueda and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kenichi Matsuo

142 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenichi Matsuo Japan 33 1.9k 1.6k 1.2k 930 815 150 3.6k
Shinji Togo Japan 37 1.7k 0.9× 2.0k 1.3× 1.7k 1.4× 1.1k 1.2× 544 0.7× 167 3.9k
Yanming Zhou China 31 1.6k 0.9× 1.6k 1.0× 1.0k 0.8× 992 1.1× 573 0.7× 112 3.3k
Akira Chikamoto Japan 34 2.0k 1.1× 1.5k 0.9× 1.1k 0.9× 922 1.0× 736 0.9× 226 4.0k
Sang Myung Woo South Korea 34 1.7k 0.9× 1.6k 1.0× 609 0.5× 1.3k 1.4× 538 0.7× 162 3.3k
Atsushi Nanashima Japan 26 685 0.4× 1.2k 0.7× 1.1k 0.9× 758 0.8× 444 0.5× 210 2.6k
Hirofumi Akita Japan 28 1.5k 0.8× 1.1k 0.7× 632 0.5× 710 0.8× 1.1k 1.3× 184 3.2k
Toshiaki Nonami Japan 33 1.4k 0.7× 1.6k 1.0× 1.5k 1.2× 622 0.7× 467 0.6× 177 3.6k
Tohru Utsunomiya Japan 37 1.7k 0.9× 978 0.6× 1.3k 1.0× 607 0.7× 1.5k 1.8× 166 4.3k
Masahiko Onda Japan 33 1.1k 0.6× 1.7k 1.0× 554 0.5× 889 1.0× 1.0k 1.3× 221 3.7k
Marcus Bahra Germany 39 2.1k 1.1× 1.7k 1.0× 1.7k 1.4× 927 1.0× 838 1.0× 209 4.8k

Countries citing papers authored by Kenichi Matsuo

Since Specialization
Citations

This map shows the geographic impact of Kenichi Matsuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenichi Matsuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenichi Matsuo more than expected).

Fields of papers citing papers by Kenichi Matsuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenichi Matsuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenichi Matsuo. The network helps show where Kenichi Matsuo may publish in the future.

Co-authorship network of co-authors of Kenichi Matsuo

This figure shows the co-authorship network connecting the top 25 collaborators of Kenichi Matsuo. A scholar is included among the top collaborators of Kenichi Matsuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenichi Matsuo. Kenichi Matsuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Irie, Hiroki, Fumio Nakagawa, Hiraku Itadani, et al.. (2020). Acquired resistance to trastuzumab/pertuzumab or to T‐DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728. Cancer Science. 111(6). 2123–2131. 26 indexed citations
2.
Sootome, Hiroshi, Hidenori Fujita, Kenjiro Ito, et al.. (2020). Futibatinib Is a Novel Irreversible FGFR 1–4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors. Cancer Research. 80(22). 4986–4997. 137 indexed citations
3.
Irie, Hiroki, Kimihiro Ito, Akio Fujioka, et al.. (2019). TAS0728, A Covalent-binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models. Molecular Cancer Therapeutics. 18(4). 733–742. 12 indexed citations
4.
Ito, Kimihiro, Makoto Nishio, Masanori Kato, et al.. (2019). TAS-121, A Selective Mutant EGFR Inhibitor, Shows Activity Against Tumors Expressing Various EGFR Mutations Including T790M and Uncommon Mutations G719X. Molecular Cancer Therapeutics. 18(5). 920–928. 10 indexed citations
5.
Yokogawa, Tatsushi, Takeshi Wakasa, Keisuke Yamamura, et al.. (2018). TAS-114, a First-in-Class Dual dUTPase/DPD Inhibitor, Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-Based Chemotherapy. Molecular Cancer Therapeutics. 17(8). 1683–1693. 22 indexed citations
6.
Abe, Naomi, Hirokazu Ohsawa, Akihiro Hashimoto, et al.. (2018). TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion Mutations. Molecular Cancer Therapeutics. 17(8). 1648–1658. 70 indexed citations
7.
Hiroshima, Yukihiko, Kenichi Matsuo, Takashi Murakami, et al.. (2017). Impact of associating liver partition and portal vein occlusion for staged hepatectomy on tumor growth in a mouse model of liver metastasis. European Journal of Surgical Oncology. 44(1). 130–138. 4 indexed citations
8.
Hiroshima, Yukihiko, Kenichi Matsuo, Daisuke Kawaguchi, et al.. (2016). A Randomized Clinical Trial of Preoperative Administration of Branched-Chain Amino Acids to Prevent Postoperative Ascites in Patients with Liver Resection for Hepatocellular Carcinoma. Annals of Surgical Oncology. 23(11). 3727–3735. 28 indexed citations
9.
Takakura, Hideki, Kuniya Tanaka, Kazuhisa Takeda, et al.. (2010). A HEPATOBILIARY CYSTADENOMA WITH OVARIAN LIKE MESENCHYMAL STROMA; PREOPERATIVE DIAGNOSTIC UNCERTAINTY. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 71(2). 489–493. 1 indexed citations
10.
Taniguchi, Koichi, Itaru Endo, Ryusei Matsuyama, et al.. (2010). A Case of Safely Resected Pancreatic head Cancer Associated with Atherosclerotic Stenosis of Superior Mesenteric Artery. The Japanese Journal of Gastroenterological Surgery. 43(1). 72–76. 4 indexed citations
11.
Tanaka, Kuniya, Chizuru Matsumoto, Hideki Takakura, et al.. (2009). Technique of right hemihepatectomy preserving ventral right anterior section guided by area of hepatic venous drainage. Surgery. 147(3). 450–458. 13 indexed citations
12.
Kosaka, Takashi, Kenichi Matsuo, Naoto Yamamoto, et al.. (2009). A CASE OF FULMINANT AMEBIC COLITIS. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 70(6). 1754–1758. 1 indexed citations
13.
Ishibe, Atsushi, Shinji Togo, Kazuteru Watanabe, et al.. (2009). Prostaglandin E1 prevents liver failure after excessive hepatectomy in the rat by up‐regulating Cyclin C, Cyclin D1, and Bclxl. Wound Repair and Regeneration. 17(1). 62–70. 14 indexed citations
14.
Tanaka, Kuniya, Hiroshi Shimada, Kenichi Matsuo, et al.. (2007). Intra-operative Blood Loss Predicts Complications After a Second Hepatectomy for Malignant Neoplasms. Annals of Surgical Oncology. 14(9). 2668–2677. 3 indexed citations
15.
Tanaka, Kuniya, Hiroshi Shimada, Michio Ueda, et al.. (2006). Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases. Surgery. 139(5). 599–607. 15 indexed citations
16.
Sekido, Hitoshi, Kenichi Matsuo, Kazuhisa Takeda, et al.. (2002). Severe fatty change of the graft liver caused by a portosystemic shunt of mesenteric varices. Transplant International. 15(5). 259–262. 7 indexed citations
17.
Sekido, Hitoshi, Kenichi Matsuo, Kazuhisa Takeda, et al.. (2002). Severe fatty change of the graft liver caused by a portosystemic shunt of mesenteric varices. Transplant International. 15(5). 259–262. 9 indexed citations
19.
Kohno, Kimitoshi, Shinichi Sato, Hiroshi Takano, Kenichi Matsuo, & Michihiko Kuwano. (1989). The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochemical and Biophysical Research Communications. 165(3). 1415–1421. 201 indexed citations
20.
Matsuo, Kenichi, et al.. (1962). Studies on Soil Hardness (Part 1) : On the Soil Hardness Tester. Nihon Dojo Hiryogaku zasshi/Nippon dojō hiryōgaku zasshi. 33(7). 343–347. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026